BioSpace News Archive

Perrigo Company plc announced that it has launched the store brand equivalent of over-the-counter Voltaren® Arthritis Pain to its retail partners and the product is now available in the U.S. nationwide.

Beroni Group, an international diversified biopharmaceutical enterprise focused on the research, development, innovation and commercialization of therapies and products for treatment of global diseases, announced that it received the first commercial order for its proprietarily developed SARS-CoV-2 Antibody Detection Kit from Forsitech Inc., a pharmaceutical trading company based in Japan.

Genetic sequencing has proven that no two cancer cases are absolutely identical, heavily depending on genetic profiles of the patients, which defines their immunity power.

Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to announce the publication of independent research, in Oncology Reports, a leading oncology journal, supporting the therapeutic potential of Kevetrin, the Company’s p53-modulating anti-cancer drug candidate, in treating Acute Myeloid Leukemia (AML

Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced that its management is scheduled to present at the H.C. Wainwright 22nd Annual Global Investment Conference

Enable Injections, Inc., a company developing and manufacturing the enFuse® platform of investigational wearable infusion devices, announced it has completed a credit facility for $25 million from Oxford Finance LLC, a specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide.

Today ClinOne announced a strategic partnership with CQuentia to bring focused and personalized molecular testing to clinical trial patients

SteriLumen Will Become Distributor in the U.S and the Greater Middle East to the Hospitality and Hotel Industry

As part of its growing portfolio of medical device and healthcare solutions, TEAM Technologies will produce point-of-care (POC) tests to assist organizations seeking the benefits of rapid testing for COVID-19.

Oncopeptides AB announces that the Company has eliminated an organizational layer to shorten the decision-making process in the US operations and to create closer collaboration between global and local functions.